References
- Astrup T., Alkjaer K., Soardi F. Partial purfication of the trypsin inhibitor in urine. Scand. J. clin. Lab. Invest. 1959; 11: 181
- Astrup T., Alkjaer K., Egeblad K. Thrombelastographic patterns produced by fibrinolytic agents incorporated in fibrin. Amer. T. Physiol. 1965; 209: 84
- Astrup T., Alkjaer K., Nissen U. Urinary trypsin inhibitor mingin): transformation into a new trypsin inhibitor by acid hydrolysis or by sialidasc. Nature (London) 1964; 203: 255
- Astrup T., Alkjaer K., Sterndorff I. The plasminogen activator in urine and the urinary trypsin inhibitor. Scand. J. clin. Lab. Invest. 1955; 7: 239
- Biggs R.M., Macfarlane R.G. Human blood coagulation and its disorders. Blackwell Scientific Publications3 edn. Oxford 1962
- Dillard G. H. L. The trypsin inhibitor of the urine in health and disease. J. Lab. clin. Med. 1950; 36: 266
- Egeblad K., Astrup T. Epsilon-aminocaproic acid and the urinary trypsin inhibitor: potentiated inhibition of urokinase-induced fibrino-lysis. Proc. Soc. exp. Biol. 1963a; 112: 1020
- Egeblad K., Astrup T. Enhancement, inhibition, and potentiation of inhibition of urokinase induced fibrinolysis by EACA. Fed. Proc. 1963b; 22, Abstract 1685
- Faarvang H.J. Relation between pituitary-adrenal system and excretion of trypsin inhibitor in urine. Proc. Soc. exp. Biol. 1958; 98: 89
- Faarvang H.J. The excretion of trypsin inhibitor in urine during normal pregnancy. Acta endocr. (Kbn.) 1959; 31: 117
- Faarvang H.J. The influence of glycocorticosteroids and cor-ticotropic hormone on output of human urinary trypsin inhibitor (and hyaluronidase inhibitor). Acta pharmacol. (Kbn.) 1962; 19: 293
- Mayehiro A. Studies of trypsin inhibitor ill urine Yokohama med. Bull. 1960; 11: 111
- Ollendorff P. Improvements in the thrombin generation test. Thrombos. Diathes. haemorrh. 1960; 4: 244
- Shulman N.R. A proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. J. biol. Chem. 1955; 213: 655
- Hearon J.Z. Kinetics of conversion of pro-thrombin to thrombin by biological activators., I, Demonstration of a prothrombin derivative which reacts with proteolytic enzyme inhibitors. J. biol. Chem. 1963; 238: 153